Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Poggibonsi

5 clinical trials in Poggibonsi, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Poggibonsi at a glance
5
clinical trials
  • Recruiting now0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Poggibonsi

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Cemiplimab
  • Sponsor:GOIRC Gruppo Oncologico Italiano Di Ricerca Clinica
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fondazione GONO G.I.
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Carboplatin
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Fondazione Oncotech Impresa Sociale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Panitumumab
  • Sponsor:Fondazione GONO G.I.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Poggibonsi

What the registry says about research in the country

01 Colorectal Cancer Research

Innovative studies focusing on metastatic colorectal cancer treatment sequences, specifically examining the effectiveness of different drug administration orders in patients who have undergone previous therapies.

  • Treatment Sequencing Optimization
  • RAS/BRAF Wild Type Analysis
  • Advanced Stage Disease Management

Research aims to improve treatment outcomes for patients with chemorefractory conditions.

02 Breast Cancer Studies

Groundbreaking research examining neoadjuvant therapy approaches for early-stage breast cancer, specifically targeting ER-positive, HER2-negative cases.

  • Pre-surgical Treatment Evaluation
  • Cell Cycle Analysis
  • Hormone Receptor-Positive Disease

Focus on evaluating combined therapeutic approaches before surgical intervention.

03 Colon Cancer Diagnostics

Advanced research utilizing circulating tumor DNA testing to enhance post-operative treatment strategies in resected colon cancer patients.

  • Post-Surgery Treatment Optimization
  • Stage III and High-Risk Stage II Cases
  • Molecular Response Monitoring

Investigating treatment intensification strategies based on molecular markers.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.